193 related articles for article (PubMed ID: 27802290)
21. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
23. Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease.
Mizutani Y; Ohdake R; Tatebe H; Higashi A; Shima S; Ueda A; Ito M; Tokuda T; Watanabe H
J Neurol; 2023 Nov; 270(11):5461-5474. PubMed ID: 37480401
[TBL] [Abstract][Full Text] [Related]
24. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.
Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
Front Immunol; 2019; 10():2253. PubMed ID: 31616427
[TBL] [Abstract][Full Text] [Related]
25. Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.
Huang YR; Xie XX; Ji M; Yu XL; Zhu J; Zhang LX; Liu XG; Wei C; Li G; Liu RT
Neurobiol Dis; 2019 Apr; 124():202-217. PubMed ID: 30481547
[TBL] [Abstract][Full Text] [Related]
26. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.
Valera E; Spencer B; Masliah E
Neurotherapeutics; 2016 Jan; 13(1):179-89. PubMed ID: 26494242
[TBL] [Abstract][Full Text] [Related]
28. The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease.
Albus A; Kronimus Y; Burg-Roderfeld M; van der Wurp H; Willbold D; Ziehm T; Dodel R; Ross JA
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759704
[TBL] [Abstract][Full Text] [Related]
29. Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.
Maetzler W; Stapf AK; Schulte C; Hauser AK; Lerche S; Wurster I; Schleicher E; Melms A; Berg D
J Alzheimers Dis; 2011; 27(1):119-26. PubMed ID: 21765209
[TBL] [Abstract][Full Text] [Related]
30. Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood.
Kuhn I; Rogosch T; Schindler TI; Tackenberg B; Zemlin M; Maier RF; Dodel R; Kronimus Y
J Neuroimmunol; 2018 Feb; 315():33-39. PubMed ID: 29306403
[TBL] [Abstract][Full Text] [Related]
31. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E
Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114
[TBL] [Abstract][Full Text] [Related]
32. Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.
Maetzler W; Tian Y; Baur SM; Gauger T; Odoj B; Schmid B; Schulte C; Deuschle C; Heck S; Apel A; Melms A; Gasser T; Berg D
PLoS One; 2012; 7(10):e48042. PubMed ID: 23133543
[TBL] [Abstract][Full Text] [Related]
33. Effect of Different Aβ Aggregates as Antigen on the Measure of Naturally Occurring Autoantibodies against Amyloid-β40/42 in IVIG.
Cao H; Du X; Zeng R; Lv Z; Ye S; Jiang P; Wang Z; Ma L; Huang Y; Li C; Zhang R; Liu F
Curr Alzheimer Res; 2019; 16(14):1290-1299. PubMed ID: 31894747
[TBL] [Abstract][Full Text] [Related]
34. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
35. The Diagnostic Potential of Circulating Autoantibodies to Amyloid-β in Alzheimer's Disease.
Xu GY; Liu YH; Zeng XQ; Chen DW; Zeng GH; Fan DY; Liu YH; Wang YJ
J Alzheimers Dis; 2023; 94(2):537-546. PubMed ID: 37334604
[TBL] [Abstract][Full Text] [Related]
36. Neuropathology of dementia in a large cohort of patients with Parkinson's disease.
Horvath J; Herrmann FR; Burkhard PR; Bouras C; Kövari E
Parkinsonism Relat Disord; 2013 Oct; 19(10):864-8; discussion 864. PubMed ID: 23746454
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
38. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
39. Naturally occurring autoantibodies against β-Amyloid.
Bach JP; Dodel R
Adv Exp Med Biol; 2012; 750():91-9. PubMed ID: 22903668
[TBL] [Abstract][Full Text] [Related]
40. Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
Jian JM; Fan DY; Cheng Y; Shen YY; Chen DW; Li HY; Chen Y; Zhang Y; Zeng GH; Tan CR; Liu YH; Wang YJ
J Alzheimers Dis; 2022; 87(2):711-719. PubMed ID: 35342089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
